Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

FACULTY

Jeannette Wick, RPh, MBA, FASCP
Visiting Professor
School of Pharmacy
University of Connecticut
Storrs, Connecticut

FINANCIAL DISCLOSURE

Jeannette Wick, RPh, MBA, FASCP has no relevant affiliation or financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.

The following reviewer, John Fanikos, RPh, MBA, has indicated the following relevant affiliation or financial relationship with a commercial interest: Consultant and Speaker for BD Rx, Inc., Boehringer Ingelheim, and Portola, Inc.

Susanne Batesko, RN, BSN, Robin Carrino, and L. Michael Posey, BSPharm, MA, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

ACCREDITATION STATEMENTS

PHARMACY

Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-16-072-H01-P

Credits: 2.0 hours (0.20 ceu)
Published: July 15, 2016
Last Review: May 8, 2018
Expires: July 15, 2019
Type of Activity: Knowledge
Media: Internet

Fee Information: $6.97

Estimated time to complete activity: 120 minutes

TARGET AUDIENCE

This accredited activity has been designed for pharmacists.

HOW TO EARN CREDIT

During the period July 15, 2016 through July 15, 2019 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

GOAL

To describe four major areas of perioperative care relevant to pharmacists practicing in acute and other care settings: antibiotic prophylaxis in surgical patients; malignant hyperthermia, safe use of alvimopan, and management of systemic toxicities of local anesthetics

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

1. Describe the prevalence and economic burden of surgical site infections.
2. Summarize Surgical Care Improvement Project performance measures and their application in the hospital including antibiotic selection, timing of initial dose, when to stop, and intraoperative re-dosing recommendations.
3. List details about the pathophysiology of malignant hyperthermia, causative agents, and the pharmacist response team's drug therapy management options and responsibilities.
4. Explain the alvimopan (Entereg) Risk Evaluation Mitigation Strategy.
5. Recognize local anesthetic systemic toxicity and be able to actively assist with emergency treatment.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.